Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Bio-Techne Corporation

Bio-Techne Corporation (TECH) Stock Overview

Explore Bio-Techne Corporation’s financial performance, market position, analyst ratings, and future outlook.

TECH●NASDAQ
HealthcareBiotechnology
$72.32
$0.04(0.06%)
U.S. Market opens in 58h 46m

Bio-Techne Corporation (TECH)

Meyka AI Score

Z

Key Financials

Market Cap11.3B
P/E Ratio61.81
EPS (TTM)$1.94
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$71.47
3 Months$80.83
1 Year Target$57.17

TECH Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Bio-Techne Corporation (NASDAQ: TECH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bio-Techne Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TECH on the NASDAQ shows an RSI of 69.17, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $57.17 for the NASDAQ listing.

Key metrics behind Bio-Techne Corporation's NASDAQ-traded stock include a P/E ratio of 61.81 and a market capitalization of 11.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TECH on the NASDAQ.

Price Performance (NASDAQ: TECH)

1-Day Change
0.06%
5-Day Change
0.12%
1-Month Change
0.96%
3-Month Change
52.67%
6-Month Change
25.73%
Year-to-Date (YTD) Change
22.97%
1-Year Change
33.93%
3-Year Change
-8.08%
5-Year Change
-39.72%
All-Time (Max) Change
66018.12%

Contact Information

https://www.bio-techne.com
612 379 8854
614 McKinley Place N.E., Minneapolis, MN, 55413

Company Facts

31,000 Employees
IPO DateFeb 9, 1989
CountryUS
Actively Trading

Frequently Asked Questions